BioElectronics Corporation
Device maker commences trading under symbol BIEL
Published in Health Business Week, May 14th, 2004
"We are pleased to open the ownership of our Company to a broader group of investors," said Andrew J. Whelan, CEO of BioElectronics Corporation. "We have a broad and deep pipeline of innovative therapeutic devices."
The company's first U.S. Food & Drug Administration (FDA) cleared product, ActiPatch Therapy is a dermal patch with an embedded microchip that delivers weeks of continuous pulsed electromagnetic energy. ActiPatch Therapy is the miniaturized equivalent of the large pulsed electromagnetic energy machines prescribed by physicians for decades to reduce...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2004-05-14)
More Articles from Health Business Week
- Affymax, Inc.
Peptide drug maker completes Series C financing, adds new board member - AngioGenex, Inc.
Oncology company completes bridge financing - Applied Imaging Corp.
Imaging company reports $4.25M private placement of common stock - Axya Medical, Inc.
Device firm completes $3M financing - BioTrove, Inc.
Lab-on-a-chip maker completes a $13.7M round of financing - Boston Biomedica, Inc.
Diagnostics, biotech divisions sold to SeraCare Life Sciences - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
